Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 30, 2021PolymersOpen Access

Serum Albumin Nanoparticles: Problems and Prospects

View Full Paper
Ask AI
Bookmark
Share

Authors

VHViktória Hornok

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Viktória Hornok (2021) studied this question.

synapsesocial.com/papers/69de72b0726bee048db0c1e2https://doi.org/10.3390/polym13213759
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Changes in plasma protein binding have little clinical relevance2002 · 828 citations
  2. 2Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.2006 · 1,192 citations
  3. 3Optimization of parameters for the fabrication of gelatin nanoparticles by the Taguchi robust design method2008 · 57 citations
  4. 4INTERMOLECULAR CROSS LINKING OF A PROTEIN IN THE CRYSTALLINE STATE: CARBOXYPEPTIDASE-A1964 · 291 citations
  5. 5Albumin-Based Nanodevices as Drug Carriers2016 · 188 citations